IMATINIB MESYLATE 400 MG TAB

Imatinib Mesylate
$3.0339per EA

Strength

400 mg/1

NDC

82009008730

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212773

On Market Since

9/1/2023

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

-5.5%

3M

-4.8%

6M

+1.7%

1Y

+9.6%

3Y

N/A

5Y

N/A

All

+70.5%